Patents by Inventor Helawe Betre

Helawe Betre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10800905
    Abstract: Disclosed is a resilient foam and methods of making the foam. The resilient foam includes a derivatized polyanionic polysaccharide and has an open-cell structure. When the resilient foam is contacted with water, the foam forms a thixotropic hydrogel.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: October 13, 2020
    Assignee: SMITH & NEPHEW, INC.
    Inventors: George T. Delli-Santi, Helawe Betre
  • Publication number: 20190136016
    Abstract: Disclosed is a resilient foam and methods of making the foam. The resilient foam includes a derivatized polyanionic polysaccharide and has an open-cell structure. When the resilient foam is contacted with water, the foam forms a thixotropic hydrogel.
    Type: Application
    Filed: January 4, 2019
    Publication date: May 9, 2019
    Applicant: Smith & Nephew, Inc.
    Inventors: George T. Delli-Santi, Helawe Betre
  • Patent number: 10227478
    Abstract: Disclosed is a resilient foam and methods of making the foam. The resilient foam includes a derivatized polyanionic polysaccharide and has an open-cell structure. When the resilient foam is contacted with water, the foam forms a thixotropic hydrogel.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: March 12, 2019
    Assignee: Smith & Nephew, Inc.
    Inventors: George T. Delli-Santi, Helawe Betre
  • Publication number: 20160024285
    Abstract: Disclosed is a resilient foam and methods of making the foam. The resilient foam includes a derivatized polyanionic polysaccharide and has an open-cell structure. When the resilient foam is contacted with water, the foam forms a thixotropic hydrogel.
    Type: Application
    Filed: June 9, 2015
    Publication date: January 28, 2016
    Inventors: George T. Delli-Santi, Helawe Betre
  • Publication number: 20140364371
    Abstract: A method for delivering a drug depot of a compound of interest to a selected region in a subject. The method comprises administering a composition directly to said region of interest, the composition comprising the compound of interest to be delivered (such as an antiinflammatory agent or a chemotherapeutic agent) and a polymer (such as an elastin-like peptide or ELP) that undergoes an inverse temperature phase transition, so that a sustained release of the compound of interest at the selected region is provided. Compositions useful for carrying out the invention are also described.
    Type: Application
    Filed: June 5, 2014
    Publication date: December 11, 2014
    Inventors: Lori A. Setton, Ashutosh Chilkoti, Virginia B. Kraus, Helawe Betre, Matthew R. Dreher
  • Publication number: 20110236384
    Abstract: A method for delivering a drug depot of a compound of interest to a selected region in a subject. The method comprises administering a composition directly to said region of interest, the composition comprising the compound of interest to be delivered (such as an antiinflammatory agent or a chemotherapeutic agent) and a polymer (such as an elastin-like peptide or ELP) that undergoes an inverse temperature phase transition, so that a sustained release of the compound of interest at the selected region is provided. Compositions useful for carrying out the invention are also described.
    Type: Application
    Filed: January 24, 2011
    Publication date: September 29, 2011
    Applicant: Duke University
    Inventors: Lori A. SETTON, Ashutosh Chilkoti, Virginia B. Kraus, Helawe Betre, Matthew R. Dreher
  • Publication number: 20070009602
    Abstract: A method for delivering a drug depot of a compound of interest to a selected region in a subject. The method comprises administering a composition directly to said region of interest, the composition comprising the compound of interest to be delivered (such as an antiinflammatory agent or a chemotherapeutic agent) and a polymer (such as an elastin-like peptide or ELP) that undergoes an inverse temperature phase transition, so that a sustained release of the compound of interest at the selected region is provided. Compositions useful for carrying out the invention are also described.
    Type: Application
    Filed: June 21, 2006
    Publication date: January 11, 2007
    Inventors: Lori Setton, Ashutosh Chilkoti, Virginia Kraus, Helawe Betre, Matthew Dreher